[ad_1]
The company added: "Given careful public health considerations and the importance of transparency, we continue to provide clear insights on all aspects of vaccine development and the regulatory pathway.".
And on Wednesday, the European Medicines Agency, which is currently studying allowing the use of several vaccines against Covid-19, announced that it had been the target of a cyberattack, without giving details about the time of the attack or the party that carried it out. .
The European Medicines Agency has confirmed that it will announce its decision on the conditional approval of the Vise-Biontec vaccine at a meeting held no later than December 29, noting that the vaccine has been approved in the UK, Bahrain and Canada.
The cyberattack comes after a series of warnings in recent months of pandemic-related hacking operations that may target Western labs and pharmaceutical companies.
“>
The US pharmaceutical company Pfizer and its German partner Biontech confirmed that documents related to the development of a vaccine against the Covid-19 disease “were illegally accessed” in a cyber attack targeting the European Medicines Agency.
The two companies expressed their belief that no personal data of the participants in the experiment had been compromised and that the agency “assured us that the cyberattack will have no effect on the schedule for its review (the vaccine).”
In a statement, Pfizer said: “It is important to note that neither the Biontech system nor the Pfizer system were compromised” in the incident, and “we did not detect any personal data hacking.”
And he continued: “We are awaiting more information from the research being carried out by the European Medicines Agency to act appropriately in accordance with European legislation.
The company added: “Given meticulous public health considerations and the importance of transparency, we continue to provide clear insights on all aspects of vaccine development and the regulatory pathway.”
And on Wednesday, the European Medicines Agency, which is currently studying allowing the use of several vaccines against Covid-19, announced that it had been the target of a cyberattack, without giving details about the time of the attack or the party that carried it out. .
The European Medicines Agency has confirmed that it will announce its decision on the conditional approval of the Vise-Biontec vaccine at a meeting held no later than December 29, noting that the vaccine has been approved in the UK, Bahrain and Canada.
The cyberattack comes after a series of warnings in recent months of pandemic-related hacking operations that may target Western labs and pharmaceutical companies.
[ad_2]
